Endocrinology, Vol 133, 1617-1623, Copyright © 1993 by Endocrine Society

ARTICLES

Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse

RR Gala and EM Shevach
Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201.

Five monoclonal antibodies (T1, T6, U5, U6, and E21) made to the external portion of the rat PRL receptor (PRL-R) were conjugated to fluorescein isothyrocynate and used to examine the presence of PRL-R on mouse lymphocytes and macrophages using analytical flow cytometry. The monoclonals were initially evaluated using Nb2 cells, a cloned line from a rat lymphoma, and NOG-8 cells, a cloned line from normal mouse mammary gland tissue, which are known to have PRL-R. All monoclonal antibodies bound to these cells, but the U5 monoclonal gave the best separation from unstained cells. CTLL-2 cells, a mouse lymphoma cell line containing interleukin-2 receptors, did not bind to any of the monoclonals. Isolated thioglycolate-induced peritoneal macrophages contained PRL-R, and the PRL-R monoclonal U5 gave the best separation from unstained cells. Eighty-five percent of macrophages constitutively had PRL-R using this monoclonal. In vivo stimulation of the popliteal lymph node by the injection of Concanavalin-A (Con-A) into the right foot pad of intact and ovariectomized (OVX) BALB/c mice induced, at the end of 10-12 h, a marked increase in interleukin-2 receptor (IL-2R) expression on CD4, CD8, and B-cells compared to the unstimulated left popliteal lymph node. The number of CD4 and CD8 cells from OVX animals with IL-2R was twice that from intact animals, whereas no difference in the percentage of B-cells with IL-2R was evident. PRL-R were constitutively expressed on 5% of the CD4 cells and 20% of the CD8 cells and were increased in the Con-A-stimulated lymph node when examined with the U5 PRL-R monoclonal. A higher percentage of CD4 and CD8 cells from OVX animals constitutively expressed PRL-R, and when stimulated with Con-A, a further increase was observed compared to the level in intact animals. Using the U5 monoclonal, over 80% of the B220 cells constitutively expressed PRL-R; however, when T1, T6, and U6 monoclonals were examined, the percentage was considerably below (20%) than that observed for U5. Con-A stimulation did not alter the percentage of B220 cells expressing PRL-R. These results show the importance of identifying lymphocyte subsets and examining a number of PRL-R monoclonals in determining lymphocyte PRL-R expression on the surface of the cell.

This article has been cited by other articles:

				A. Tripathi and A. Sodhi Prolactin-induced production of cytokines in macrophages in vitro involves JAK/STAT and JNK MAPK pathways Int. Immunol., March 1, 2008; 20(3): 327 - 336. [Abstract] [Full Text] [PDF]

				L Daza, C Lavalle, C Duarte, R Huerta, and J Moreno Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus Lupus, February 1, 2003; 12(2): 107 - 111. [Abstract] [PDF]

				M. W. Knoferl, M. K. Angele, A. Ayala, W. G. Cioffi, K. I. Bland, and I. H. Chaudry Insight into the mechanism by which metoclopramide improves immune functions after trauma-hemorrhage Am J Physiol Cell Physiol, July 1, 2000; 279(1): C72 - C80. [Abstract] [Full Text] [PDF]

				K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]

				K. M. McAveney, M. L. Book, P. Ling, J. Chebath, and L.-y. Yu-Lee Association of 2',5'-Oligoadenylate Synthetase with the Prolactin (PRL) Receptor: Alteration in PRL-Inducible Stat1 (Signal Transducer and Activator of Transcription 1) Signaling to the IRF-1 (Interferon-Regulatory Factor 1) Promoter Mol. Endocrinol., February 1, 2000; 14(2): 295 - 306. [Abstract] [Full Text]

				R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]